Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118727522 | 11872752 | 2 | F | 20000329 | 20160826 | 20151228 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-11048691 | BRISTOL MYERS SQUIBB | 1.00 | DY | M | Y | 3.18000 | KG | 20160826 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118727522 | 11872752 | 1 | PS | ZERIT | STAVUDINE | 1 | Transplacental | UNK | U | 20412 | CAPSULE, HARD | ||||||||
| 118727522 | 11872752 | 2 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | 150 MG, UNK | U | 0 | 150 | MG | |||||||
| 118727522 | 11872752 | 3 | SS | VIRAMUNE | NEVIRAPINE | 1 | Transplacental | 200 MG, UNK | Y | 0 | 200 | MG | |||||||
| 118727522 | 11872752 | 4 | SS | VIRAMUNE | NEVIRAPINE | 1 | Oral | UNK | U | 0 | |||||||||
| 118727522 | 11872752 | 5 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118727522 | 11872752 | 6 | SS | RETROVIR | ZIDOVUDINE | 1 | Oral | UNK | U | 0 | |||||||||
| 118727522 | 11872752 | 7 | C | SALAZOPYRINE | SULFASALAZINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118727522 | 11872752 | 8 | C | I RON | FERROUS FUMARATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118727522 | 11872752 | 9 | C | CORTANCYL | PREDNISONE | 1 | Transplacental | EXPOSURE DURING GESTATION. | U | 0 | |||||||||
| 118727522 | 11872752 | 10 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118727522 | 11872752 | 1 | Product used for unknown indication |
| 118727522 | 11872752 | 2 | Product used for unknown indication |
| 118727522 | 11872752 | 3 | Product used for unknown indication |
| 118727522 | 11872752 | 4 | Prophylaxis against HIV infection |
| 118727522 | 11872752 | 5 | Product used for unknown indication |
| 118727522 | 11872752 | 6 | Prophylaxis against HIV infection |
| 118727522 | 11872752 | 7 | Product used for unknown indication |
| 118727522 | 11872752 | 8 | Product used for unknown indication |
| 118727522 | 11872752 | 9 | Product used for unknown indication |
| 118727522 | 11872752 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118727522 | 11872752 | HO |
| 118727522 | 11872752 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118727522 | 11872752 | Anaemia | |
| 118727522 | 11872752 | Foetal exposure during pregnancy | |
| 118727522 | 11872752 | Hepatomegaly | |
| 118727522 | 11872752 | Hypertonia | |
| 118727522 | 11872752 | Hypotonia | |
| 118727522 | 11872752 | Neutropenia | |
| 118727522 | 11872752 | Thrombocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118727522 | 11872752 | 1 | 19990810 | 0 | ||
| 118727522 | 11872752 | 2 | 200002 | 0 | ||
| 118727522 | 11872752 | 3 | 19990810 | 0 | ||
| 118727522 | 11872752 | 4 | 20000331 | 0 | ||
| 118727522 | 11872752 | 6 | 20000328 | 20000512 | 0 | |
| 118727522 | 11872752 | 7 | 19991215 | 0 |